NO20073368L - Amid-promedikament av gemcitabin, sammensetninger og anvendelse derav - Google Patents

Amid-promedikament av gemcitabin, sammensetninger og anvendelse derav

Info

Publication number
NO20073368L
NO20073368L NO20073368A NO20073368A NO20073368L NO 20073368 L NO20073368 L NO 20073368L NO 20073368 A NO20073368 A NO 20073368A NO 20073368 A NO20073368 A NO 20073368A NO 20073368 L NO20073368 L NO 20073368L
Authority
NO
Norway
Prior art keywords
gemcitabine
compositions
amide prodrug
amide
prodrug
Prior art date
Application number
NO20073368A
Other languages
English (en)
Norwegian (no)
Inventor
David Michael Remick
David Michael Bender
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20073368L publication Critical patent/NO20073368L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
NO20073368A 2004-12-17 2007-06-29 Amid-promedikament av gemcitabin, sammensetninger og anvendelse derav NO20073368L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63742204P 2004-12-17 2004-12-17
PCT/US2005/043125 WO2006065525A1 (en) 2004-12-17 2005-11-30 Amide prodrug of gemcitabine, compositions and use thereof

Publications (1)

Publication Number Publication Date
NO20073368L true NO20073368L (no) 2007-07-16

Family

ID=36168678

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073368A NO20073368L (no) 2004-12-17 2007-06-29 Amid-promedikament av gemcitabin, sammensetninger og anvendelse derav

Country Status (32)

Country Link
US (1) US7691827B2 (de)
EP (1) EP1831237B1 (de)
JP (1) JP5022911B2 (de)
KR (1) KR100874052B1 (de)
CN (1) CN101080417B (de)
AR (1) AR055009A1 (de)
AT (1) ATE405573T1 (de)
AU (1) AU2005316922B2 (de)
BR (1) BRPI0519117A2 (de)
CA (1) CA2589850C (de)
CY (1) CY1108447T1 (de)
DE (1) DE602005009255D1 (de)
DK (1) DK1831237T3 (de)
EA (1) EA011868B1 (de)
ES (1) ES2310860T3 (de)
HK (1) HK1109903A1 (de)
HR (1) HRP20080529T3 (de)
IL (1) IL183666A (de)
MA (1) MA29154B1 (de)
MX (1) MX2007007228A (de)
MY (1) MY143677A (de)
NO (1) NO20073368L (de)
NZ (1) NZ554732A (de)
PE (1) PE20060771A1 (de)
PL (1) PL1831237T3 (de)
PT (1) PT1831237E (de)
RS (1) RS50629B (de)
SI (1) SI1831237T1 (de)
TW (1) TWI326687B (de)
UA (1) UA86119C2 (de)
WO (1) WO2006065525A1 (de)
ZA (1) ZA200705019B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009000198A (es) * 2006-06-21 2009-01-22 Lilly Co Eli Formas cristalinas de profarmaco amida de gemcitabina, composiciones y usos del mismo.
TWI436775B (zh) 2007-08-24 2014-05-11 Oncotherapy Science Inc 以抗原胜肽合併化療藥劑治療胰臟癌
CN101525361B (zh) * 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
CN104955458A (zh) 2012-11-07 2015-09-30 Z·索 取代的吉西他滨芳基酰胺类似物和使用所述类似物的治疗方法
KR20150082606A (ko) 2012-11-13 2015-07-15 보옌 테라퓨틱스, 인크. 겜시타빈 전구약물 및 그의 용도
US10059733B2 (en) 2014-03-03 2018-08-28 Nucorion Pharmaceuticals, Inc. Gemcitabine analogs
WO2016078160A1 (zh) * 2014-11-17 2016-05-26 常州方圆制药有限公司 胞苷衍生物及其应用
US10435429B2 (en) 2017-10-03 2019-10-08 Nucorion Pharmaceuticals, Inc. 5-fluorouridine monophosphate cyclic triester compounds
WO2019139920A1 (en) 2018-01-10 2019-07-18 Nucorion Pharmaceuticals, Inc. Phosphor(n)amidatacetal and phosph(on)atalcetal compounds
US11427550B2 (en) 2018-01-19 2022-08-30 Nucorion Pharmaceuticals, Inc. 5-fluorouracil compounds
MX2020008188A (es) 2018-02-02 2020-11-18 Maverix Oncology Inc Conjugados de fármacos de molécula pequeña de monofosfato de gemcitabina.
CN113166189A (zh) * 2018-04-26 2021-07-23 纳米医学控股有限公司 吉西他滨两亲性前体药物
CN108864250A (zh) * 2018-05-29 2018-11-23 北京大学 一种FAPα酶敏感的吉西他滨前体药物及其制备方法和应用
EP3817732A4 (de) * 2018-08-03 2022-06-08 Cellix Bio Private Limited Zusammensetzungen und verfahren zur krebsbehandlung
US12110311B2 (en) 2019-07-17 2024-10-08 Nucorion Pharmaceuticals, Inc. Cyclic deoxyribonucleotide compounds
WO2021216427A1 (en) 2020-04-21 2021-10-28 Ligand Pharmaceuticals, Inc. Nucleotide prodrug compounds
PL442924A1 (pl) * 2022-11-23 2024-05-27 Politechnika Śląska Prolek - glikokoniugat pochodny gemcytabiny, jako związek o działaniu przeciwnowotworowym, sposób otrzymywania i zastosowanie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
RU2131880C1 (ru) * 1992-06-22 1999-06-20 Эли Лилли Энд Компани Способ получения обогащенных бета-аномером нуклеозидов
GB2321454A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Gemcitabine esters and amides
PL186888B1 (pl) * 1997-01-24 2004-03-31 Conpharma As Pochodne gemcytabiny
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6624142B2 (en) * 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
US6376470B1 (en) * 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
AU2003291726A1 (en) 2002-11-04 2004-06-07 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
US7846436B2 (en) * 2003-11-28 2010-12-07 Chemgenes Corporation Oligonucleotides and related compounds

Also Published As

Publication number Publication date
US20090156547A1 (en) 2009-06-18
EA200701300A1 (ru) 2007-10-26
PL1831237T3 (pl) 2009-01-30
EP1831237A1 (de) 2007-09-12
PT1831237E (pt) 2008-09-22
TW200634023A (en) 2006-10-01
KR20070086308A (ko) 2007-08-27
MA29154B1 (fr) 2008-01-02
CN101080417A (zh) 2007-11-28
BRPI0519117A2 (pt) 2008-12-23
ES2310860T3 (es) 2009-01-16
CY1108447T1 (el) 2014-04-09
CA2589850A1 (en) 2006-06-22
DK1831237T3 (da) 2008-10-27
US7691827B2 (en) 2010-04-06
EP1831237B1 (de) 2008-08-20
AU2005316922B2 (en) 2011-08-25
KR100874052B1 (ko) 2008-12-12
IL183666A0 (en) 2007-09-20
HK1109903A1 (en) 2008-06-27
CA2589850C (en) 2012-05-01
ZA200705019B (en) 2008-10-29
ATE405573T1 (de) 2008-09-15
WO2006065525A1 (en) 2006-06-22
JP2008524218A (ja) 2008-07-10
UA86119C2 (ru) 2009-03-25
DE602005009255D1 (de) 2008-10-02
CN101080417B (zh) 2011-01-19
HRP20080529T3 (en) 2008-12-31
AU2005316922A1 (en) 2006-06-22
NZ554732A (en) 2010-09-30
EA011868B1 (ru) 2009-06-30
MX2007007228A (es) 2007-08-14
SI1831237T1 (sl) 2009-02-28
JP5022911B2 (ja) 2012-09-12
AR055009A1 (es) 2007-08-01
RS50629B (sr) 2010-06-30
TWI326687B (en) 2010-07-01
PE20060771A1 (es) 2006-09-23
MY143677A (en) 2011-06-30
IL183666A (en) 2011-09-27

Similar Documents

Publication Publication Date Title
NO20073368L (no) Amid-promedikament av gemcitabin, sammensetninger og anvendelse derav
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
EA200971051A1 (ru) Ингибиторы p70 s6 киназы
CY1112402T1 (el) Ενισχυτες υποδοχεων γλουταμικου
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
CY1113314T1 (el) (3-αρυλ-πιπεραζιν-1-υλ) παραγωγα της 6,7-διαλκοξυκιναζολινης, 6,7-διαλκοξυφθαλαζινης και 6,7-διαλκοξυϊσοκινολινης
CY1111752T1 (el) Πυρρολοπυραζολες, δυναμικοι αναστολεις κινασης
EA200702048A1 (ru) Фармакокинетически улучшенные соединения
UA101478C2 (ru) Соединения, полезные как ингибиторы raf-киназы
MX2008001538A (es) Aril piridinas y metodos para su uso.
DK3530673T3 (da) Humaniserede anti-beta7-antagonister og anvendelser deraf
TW200604184A (en) Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
CY1109006T1 (el) Παραγωγα πουρινης ως αναστολεις κινασης
MX2010006738A (es) Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos.
MX2010006736A (es) Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos.
TW200732349A (en) Anti-OX40L antibodies and methods using same
TW200640924A (en) VEGF-R2 inhibitors and methods
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
TW200624426A (en) BACE inhibitors
DK1761520T3 (da) Kinaseinhibitorer
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
UA85505C2 (en) Kinase inhibitors
TW200621744A (en) Mercaptoamides as histone deacetylase inhibitors
NO20080661L (no) Nye cystein-protease-inhibitorer og deres terapeutiske anvendelser
MX2009000198A (es) Formas cristalinas de profarmaco amida de gemcitabina, composiciones y usos del mismo.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application